BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)
Clinical trial NCT03127735 · COMPLETED
Trial details
- NCT number
- NCT03127735
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-14
- Primary completion
- 2018-12-06
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.